Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sominex Composto
- Development stage
- Unknown
- Lead developer
- EMS
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sominex Composto is a traditional herbal medicinal product developed and manufactured by EMS S/A in Brazil. It is a fixed-dose combination of three plant extracts: *Valeriana officinalis* (Valerian), *Crataegus oxyacantha* (Hawthorn), and *Passiflora incarnata* (Passionflower). The product is indicated as a mild sedative and for the treatment of sleep disturbances (insomnia) associated with anxiety. Its mechanism of action involves the synergistic modulation of the GABAergic system, primarily through interactions with Gamma-aminobutyric acid type A (GABA-A) and type B (GABA-B) receptors. Valerian and Passionflower are known to enhance GABAergic signaling, leading to reduced cerebral activity and sleep induction, while Hawthorn contributes relaxing properties that help alleviate anxiety symptoms. It is formulated as an oral small molecule product.
- Brand names
- Sominex CompostoSominex
- Other names
- Valeriana officinalis + Crataegus oxyacantha + Passiflora incarnata
02
Targets
HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)GABAA (Gamma-aminobutyric acid receptor)GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on Sominex Composto.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sominex Composto.